-+ 0.00%
-+ 0.00%
-+ 0.00%

Oppenheimer Downgrades Crescent Capital BDC to Perform, Lowers Price Target to $16

Benzinga·05/15/2026 13:21:18
Listen to the news
Oppenheimer analyst Mitchel Penn downgrades Crescent Capital BDC (NASDAQ:CCAP) from Outperform to Perform and lowers the price target from $19 to $16.